Get the latest Science News and Discoveries

Dana-Farber Phase 1 study explores toxicity reduction in combination of trastuzumab deruxtecan and olaparib in advanced HER2-expressing malignancies - EurekAlert!

Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Related news:

Study points to new treatment target for fatal infant heart disease - EurekAlert!

Black hole jets pack the power of 10,000 Suns, study confirms

Study suggests link between prenatal exposure to certain medications and increased autism risk - EurekAlert!